The effect of the acute inflammatory response of burns and its treatment on clot characteristics and quality: A prospective case controlled study

Burns. 2020 Aug;46(5):1051-1059. doi: 10.1016/j.burns.2019.11.008. Epub 2019 Dec 20.

Abstract

Introduction: Burns are known to have an effect on coagulation in the early period after burn. Current coagulation tests have been criticised in acute burns due to their inherent limitations. This study aims to investigate the potential for a new quantitative functional biomarker of clot quality, fractal dimension, to identify changes in clot microstructure as a result of the burn inflammatory response and its treatment.

Methods: A total of fifty-eight burn patients were included in this prospective case-controlled study. The control group (29 patients mean TBSA 1%), and case group (29 patients mean TBSA 30%) were compared at baseline and the case group investigated further over four time points (baseline, 12h, 24h and 5-7 days). Fractal analysis was performed, as well as current markers of coagulation, inflammatory markers and point-of-care tests, Thromboelastography and Multiplate analysis.

Results: Fractal dimension did not differ between groups at admission (1.73±0.06 and 1.72±0.1), and fell within the healthy index normal range (1.74±0.7), suggesting a normal clot microstructure in the early period after burn. Fractal dimension significantly reduced from baseline over the first 24h following injury (1.59±0.03 p<0.005), indicating a significant reduction in mechanical clot strength and functionality consistent with a hypocoagulable state, not identified with other markers.

Conclusions: This is the first study to quantify the changes in clot microstructure following burn injury. This study confirms clot microstructure is significantly altered during the first 24h after burn, with the production of a weaker, more porous fibrin clot, consistent with a hypocoagulable state.

Keywords: Biomarker; Burns; Clot microstructure; Coagulation; Thermal injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Coagulation Disorders / blood*
  • Blood Coagulation Disorders / metabolism
  • Blood Coagulation Disorders / pathology
  • Blood Coagulation Tests
  • Burns / blood*
  • Burns / pathology
  • Burns / therapy
  • Case-Control Studies
  • Colloids / therapeutic use
  • Disease Progression
  • Factor VIII / metabolism
  • Female
  • Fibrin Fibrinogen Degradation Products / metabolism
  • Fluid Therapy / methods
  • Fractals
  • Humans
  • Inflammation / blood*
  • Inflammation / metabolism
  • Interleukin-6 / metabolism
  • Male
  • Microscopy, Electron, Scanning
  • Middle Aged
  • Platelet Aggregation
  • Platelet Function Tests
  • Procalcitonin / metabolism
  • Prospective Studies
  • Thrombelastography
  • Tumor Necrosis Factor-alpha / metabolism
  • Young Adult

Substances

  • Colloids
  • Fibrin Fibrinogen Degradation Products
  • Interleukin-6
  • Procalcitonin
  • Tumor Necrosis Factor-alpha
  • fibrin fragment D
  • Factor VIII